The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases
Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)
|3||Active, not recruiting||
Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
† Study has passed its completion date and status has not been verified in more than two years.